Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 5
1995 11
1996 13
1997 2
1998 20
1999 18
2000 26
2001 42
2002 48
2003 47
2004 53
2005 49
2006 52
2007 46
2008 81
2009 66
2010 63
2011 72
2012 54
2013 64
2014 56
2015 66
2016 63
2017 49
2018 47
2019 28
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

1,027 results
Results by year
Filters applied: . Clear all
Page 1
Mechanism and regulation of the nonsense-mediated decay pathway.
Hug N, Longman D, Cáceres JF. Hug N, et al. Nucleic Acids Res. 2016 Feb 29;44(4):1483-95. doi: 10.1093/nar/gkw010. Epub 2016 Jan 14. Nucleic Acids Res. 2016. PMID: 26773057 Free PMC article. Review.
Engineered transfer RNAs for suppression of premature termination codons.
Lueck JD, Yoon JS, Perales-Puchalt A, Mackey AL, Infield DT, Behlke MA, Pope MR, Weiner DB, Skach WR, McCray PB Jr, Ahern CA. Lueck JD, et al. Nat Commun. 2019 Feb 18;10(1):822. doi: 10.1038/s41467-019-08329-4. Nat Commun. 2019. PMID: 30778053 Free PMC article.
Single-Molecule Imaging Uncovers Rules Governing Nonsense-Mediated mRNA Decay.
Hoek TA, Khuperkar D, Lindeboom RGH, Sonneveld S, Verhagen BMP, Boersma S, Vermeulen M, Tanenbaum ME. Hoek TA, et al. Mol Cell. 2019 Jul 25;75(2):324-339.e11. doi: 10.1016/j.molcel.2019.05.008. Epub 2019 May 30. Mol Cell. 2019. PMID: 31155380 Free PMC article.
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E; Clinical Evaluator Training Group; ACT DMD Study Group. McDonald CM, et al. Lancet. 2017 Sep 23;390(10101):1489-1498. doi: 10.1016/S0140-6736(17)31611-2. Epub 2017 Jul 17. Lancet. 2017. PMID: 28728956 Clinical Trial.
PTC124 targets genetic disorders caused by nonsense mutations.
Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon YC, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL. Welch EM, et al. Nature. 2007 May 3;447(7140):87-91. doi: 10.1038/nature05756. Epub 2007 Apr 22. Nature. 2007. PMID: 17450125
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression.
Roy B, Friesen WJ, Tomizawa Y, Leszyk JD, Zhuo J, Johnson B, Dakka J, Trotta CR, Xue X, Mutyam V, Keeling KM, Mobley JA, Rowe SM, Bedwell DM, Welch EM, Jacobson A. Roy B, et al. Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12508-12513. doi: 10.1073/pnas.1605336113. Epub 2016 Oct 4. Proc Natl Acad Sci U S A. 2016. PMID: 27702906 Free PMC article.
1,027 results
Jump to page
Feedback